USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ONCOIMMUNE, INC.
Address:
12111 Parklawn Drive
Suite 105
Rockville, MD 20852
Phone:
N/A
URL:
EIN:
204167359
DUNS:
146678516
Number of Employees:
8
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $305,333.00 2

Award List:

Targeting host response to DAMP for therapy of Rheumatoid Arthritis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$150,153.00
Agency:
HHS
Principal Investigator:
Dexing Fang – 734-615-3158
Abstract:
DESCRIPTION (provided by applicant): Rheumatoid arthritis (RA) is among the most common autoimmune diseases. The current treatment for RA is mainly by targeting tumor-necrosis factor (TNF). Despite the remarkable efficacy, significant portion of RA patients are not responsive to this class of drugs.… More

Novel Therapeutics for Sepsis

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$155,180.00
Agency:
HHS
Principal Investigator:
Dexing Fang – 734-332-4234
Abstract:
DESCRIPTION (provided by applicant): Sepsis is one of the top leading causes of deaths for Americans and it is responsible for approximately 200,000 deaths in US annually. Despite of the advance of antibiotics and medical treatment in general, there has been no reduction in severity and death… More